CVE-2016-0544
Unspecified vulnerability in the Oracle Marketing component in Oracle E-Business Suite 11.5.10.2...
Unspecified vulnerability in the Oracle Marketing component in Oracle E-Business Suite 11.5.10.2 allows remote attackers to affect confidentiality and integrity via unknown vectors related to Architecture.
Exploit likelihood
What each source reports
NVD Score used
Unspecified vulnerability in the Oracle Marketing component in Oracle E-Business Suite 11.5.10.2 allows remote attackers to affect confidentiality and integrity via unknown vectors related to Architecture.
- Record
CVE-2016-0544- CVSS 2.0
- 6.4 Medium
AV:N/AC:L/Au:N/C:P/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Unspecified vulnerability in the Oracle Marketing component in Oracle E-Business Suite 11.5.10.2 allows remote attackers to affect confidentiality and integrity via unknown vectors related to Architecture.
- Record
CVE-2016-0544- Updated
- 2026-11-02
EUVDEUVD-2016-0579 No score
Unspecified vulnerability in the Oracle Marketing component in Oracle E-Business Suite 11.5.10.2 allows remote attackers to affect confidentiality and integrity via unknown vectors related to Architecture.
- Record
EUVD-2016-0579- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-86vw-fwxw-fvw9 No score
Unspecified vulnerability in the Oracle Marketing component in Oracle E-Business Suite 11.5.10.2...
Unspecified vulnerability in the Oracle Marketing component in Oracle E-Business Suite 11.5.10.2 allows remote attackers to affect confidentiality and integrity via unknown vectors related to Architecture.
- Record
GHSA-86vw-fwxw-fvw9- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2016-0544 is a medium vulnerability (CVSS 6.4) in Oracle Marketing, published January 21, 2016. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.82%, the 78th percentile. No source names a fixed version.